Notice2021-16849
Submission for OMB Review; 30-Day Comment Request; Post-Award Reporting Requirements Including Research Performance Progress Report Collection (Office of the Director)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 6, 2021
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
In compliance with the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 149 (Friday, August 6, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 149 (Friday, August 6, 2021)]
[Notices]
[Pages 43258-43260]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-16849]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day Comment Request; Post-Award
Reporting Requirements Including Research Performance Progress Report
Collection (Office of the Director)
AGENCY: National Institutes of Health, Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has submitted to the Office of
Management and Budget (OMB) a request for review and approval of the
information collection listed below.
DATES: Comments regarding this information collection are best assured
of having their full effect if received within 30-days of the date of
this publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact: Ms. Mikia P. Currie, Program Analyst, Office of
Policy for Extramural Research Administration, 6705 Rockledge Drive,
Suite 350, Bethesda, Maryland 20892, or call a non-toll-free number
301-435-0941 or Email your request, including your address to
<a href="/cdn-cgi/l/email-protection#6232100d08070116210e070310030c01072010030c010a220f030b0e4c0c0b0a4c050d14"><span class="__cf_email__" data-cfemail="0353716c69666077406f666271626d60664171626d606b436e626a6f2d6d6a6b2d646c75">[email protected]</span></a>. Formal requests for additional
plans and instruments must be requested in writing.
SUPPLEMENTARY INFORMATION: This proposed information collection was
previously published in the Federal Register on April 12, 2021, pages
18994-18995 (86 FR 18994) and allowed 60 days for public comment. No
public comments were received. The purpose of this notice is to allow
an additional 30 days for public comment. The Office of the Director
(OD) Office of Policy and Extramural Research Administration (OPERA),
National Institutes of Health, may not conduct or sponsor, and the
respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
In compliance with Section 3507(a)(1)(D) of the Paperwork Reduction
Act of 1995, the National Institutes of Health (NIH) has submitted to
the Office of Management and Budget (OMB) a request for review and
approval of the information collection listed below.
Proposed Collection: Public Health Service (PHS) Post-award
Reporting Requirements Including Research Performance Progress Report
Collection, Revision, OMB 0925-0002, Expiration Date 2/28/2023, Office
of the Director (OD), National Institutes of Health (NIH).
Need and Use of Information Collection: This collection is being
revised to omit the Inclusion Enrollment
[[Page 43259]]
Report form, which is being converted to a Common form to include the
Department of Defense (DoD). The Inclusion Enrollment Report is used
for all applications involving NIH-defined clinical research. This form
is used to report both planned and cumulative (or actual) enrollment,
and describes the sex/gender, race, and ethnicity of the study
participants. Starting in January 2022, NIH will require will
applicants and recipients to provide their Unique Entity Identifier
(UEI) instead of the Data Universal Number System (DUNS) number. Also,
the application forms will be updated to align with the <a href="http://Grants.gov">Grants.gov</a>
updated Country and State lists. NIH also anticipates adding an
optional field to the end of our forms and applications to get a more
accurate assessment of the time it takes our applicants to complete the
various forms and applications. The RPPR is required to be used by all
NIH, Food and Drug Administration, Centers for Disease Control and
Prevention, and Agency for Healthcare Research and Quality (AHRQ)
grantees. Interim progress reports are required to continue support of
a PHS grant for each budget year within a competitive segment. The
phased transition to the RPPR required the maintenance of dual
reporting processes for a period of time. Continued use of the PHS Non-
competing Continuation Progress Report (PHS 2590), exists for a small
group of grantees. This collection also includes other PHS post-award
reporting requirements: PHS 416-7 NRSA Termination Notice, PHS 2271
Statement of Appointment, 6031-1 NRSA Annual Payback Activities
Certification, HHS 568 Final Invention Statement and Certification,
iEdison, and PHS 3734 Statement Relinquishing Interests and Rights in a
PHS Research Grant. The PHS 416-7, 2271, and 6031-1 is used by NRSA
recipients to activate, terminate, and provide for payback of a NRSA.
Closeout of an award requires a Final Invention Statement (HHS 568) and
Final Progress Report. iEdison allows grantees and Federal agencies to
meet statutory requirements for reporting inventions and patents. The
PHS 3734 serves as the official record of grantee relinquishment of a
PHS award when an award is transferred from one grantee institution to
another. Pre-award reporting requirements are simultaneously
consolidated under 0925-0001 and the changes to the collection here are
related. Clinical trials are complex and challenging research
activities. Oversight systems and tools are critical for NIH to ensure
participant safety, data integrity, and accountability of the use of
public funds. NIH has been engaged in a multi-year effort to examine
how clinical trials are supported and the level of oversight needed.
The collection of more structured information in the PHS applications
and pre-award reporting requirements as well as continued monitoring
and update during the post-award reporting requirements will facilitate
NIH's oversight of clinical trials. In addition, some of the data
reported in the RPPR will ultimately be accessible to investigators to
update certain sections of forms when registering or reporting their
trials with <a href="http://ClinicalTrials.gov">ClinicalTrials.gov</a>. Frequency of response: Applicants may
submit applications for published receipt dates. For NRSA awards,
fellowships are activated, and trainees appointed.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 532,249.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Information collection forms Number of responses per per response Total annual
respondents respondent (in hours) burden hours
----------------------------------------------------------------------------------------------------------------
Reporting
----------------------------------------------------------------------------------------------------------------
PHS 416-7....................................... 12,580 1 30/60 6,290
PHS 6031-1...................................... 1,778 1 20/60 593
PHS 568......................................... 11,180 1 5/60 932
iEdison......................................... 5,697 1 15/60 1,424
PHS 2271........................................ 22,035 1 15/60 5,509
PHS 2590........................................ 243 1 18 4,374
RPPR--Core Data................................. 32,098 1 8 256,784
Biosketch (Part of RPPR)........................ 2,544 1 2 5,088
Data Tables (Part of RPPR)...................... 758 1 4 3,032
Trainee Diversity Report (Part of RPPR)......... 480 1 15/60 120
PHS Human Subjects and Clinical Trial 6,420 1 4 25,680
Information (Part of RPPR, includes inclusion
enrollment report).............................
Publication Reporting........................... 97,023 3 5/60 24,256
Final RPPR--Core Data........................... 18,000 1 10 180,000
Data Tables (Part of Final RPPR)................ 758 1 4 3,032
Trainee Diversity Report (Part of Final RPPR)... 480 1 15/60 120
PHS Human Subjects and Clinical Trial 3,600 1 4 14,400
Information (Part of RPPR, includes inclusion
enrollment report))............................
PHS 374......................................... 479 1 30/60 240
---------------------------------------------------------------
Reporting Burden Total...................... .............. .............. .............. 531,874
----------------------------------------------------------------------------------------------------------------
Recordkeeping
----------------------------------------------------------------------------------------------------------------
SBIR/STTR Life Cycle Certification.............. 1,500 1 15/60 375
---------------------------------------------------------------
Grand Total................................. 217,653 411,699 .............. 532,249
----------------------------------------------------------------------------------------------------------------
[[Page 43260]]
Dated: July 30, 2021.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2021-16849 Filed 8-5-21; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 6, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.